Trump to order drive for improved flu vaccine

16 July 2019 - President Donald Trump is readying an executive order that would direct HHS to overhaul the development ...

Read more →

New drugs: where did we go wrong and what can we do better?

10 July 2019 - More than half of new drugs entering the German health care system have not been shown to ...

Read more →

GSK welcomes the UK trial of subscription-style payment system for pharma companies to incentivise creation of new antibiotics

9 July 2019 - GSK is committed to tackling antimicrobial resistance as part of a sustained, multi-stakeholder response to this global ...

Read more →

UK launches subscription style payment pilot to incentivise pharma antibiotics R&D

9 July 2019 - The UK is to try out a subscription-style payment model aimed at incentivising pharma and biotech ...

Read more →

FDA takes new step to help advance the transition of certain biological products

27 June 2019 - Today the U.S. FDA issued a proposed rule to amend its regulations on the use of master ...

Read more →

FDA takes steps to spark development of heart failure drugs

27 June 2019 - The draft guidance, Treatment for Heart Failure: Endpoints for Drug Development, when finalised, will describe the agency’s ...

Read more →

Incorporating patient preferences in non-inferiority trials

24 June 2019 - Non-inferiority trials imply a trade-off between a loss in efficacy of a standard treatment in exchange for ...

Read more →

Sustainable discovery and development of antibiotics — is a non-profit approach the future?

19 June 2019 - Shifting to a nonprofit-driven model for development of antibiotics could encourage discovery and development of truly needed ...

Read more →

Pharma blockchains AI for drug development

15 June 2019 - The venture would allow AI to be trained on millions of datapoints across databases from several drug ...

Read more →

Pfizer denies report it hid possible Alzheimer’s breakthrough

5 June 2019 - Pfizer is fighting back against a report that it hid the potential of a blockbuster drug ...

Read more →

Pharma groups combine to promote drug discovery with AI

5 June 2019 - Blockchain system allows companies to share data without revealing commercial secrets. ...

Read more →

Pfizer knew drug may prevent Alzheimer's. Why didn't it tell us?

5 June 2019 - A team of researchers inside Pfizer made a startling find in 2015: the company's blockbuster rheumatoid ...

Read more →

EMA facilitates early engagement with medicine developers to combat antimicrobial resistance

24 May 2019 - As of today, EMA is opening up the early dialogue available through its Innovation Task Force ...

Read more →

Taxpayers are funding expensive drug development, report says

10 May 2019 - The Dutch government invests tens of millions of euros every year in small biotech companies which ...

Read more →

The antibiotic industry is broken

2 May 2019 - Take inspiration from the entertainment industry. ...

Read more →